株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

MediPoint:心臓補助装置 - 世界市場の分析と予測

MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts

発行 GlobalData 商品コード 290468
出版日 ページ情報 英文 250 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
MediPoint:心臓補助装置 - 世界市場の分析と予測 MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts
出版日: 2013年03月31日 ページ情報: 英文 250 Pages
概要

当レポートでは、世界の心臓補助装置(CAD)市場について調査分析し、疾患の概要、競合評価、アンメットニーズと機会、パイプライン製品について検証し、産業の概要、企業プロファイル、国別の見通しと予測などを提供して、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 疾患の概要:鬱血性心不全

  • 解剖学・生理学
  • 病態生理学
  • 心疾患の種類
  • 病因
  • 臨床所見
  • 心疾患の診断
  • 疫学
  • 疫学予測
  • 臨床転帰
  • 治療法
  • 経済的影響

第4章 競合評価

  • CAD市場:主な上市製品の比較
  • 心室補助装置(VAD)市場:主な企業シェア
  • VAD:ポンプ技術の比較
  • VAD
  • 体外VAD
  • 体内VAD
  • 経皮的VAD
  • 大動脈内バルーンポンプ(IABP)
  • 大動脈外バルーンポンプ
  • 完全人工心臓(TAH)
  • 膜型人口肺(ECMO)

第5章 アンメットニーズと機会

  • アンメットニーズ
  • 機会

第6章 パイプライン製品

  • 概要
  • VAD
  • 経皮的VAD
  • TAH

第7章 現在/将来の主要企業

  • 企業プロファイル
    • Abiomed, Inc.
    • Berlin Heart
    • CardiacAssist, Inc.
    • CardioBridge
    • Carmat
    • CircuLite
    • HeartWare International, Inc.
    • Jarvik Heart
    • Maquet Cardiovascular
    • Medos Medizintechnik AG
    • MicroMed Cardiovascular, Inc.
    • MiTiHeart Corporation
    • PulseCath BV
    • Sunshine Heart
    • SynCardia Systems, Inc.
    • Teleflex Medical
    • テルモ
    • Thoratec
    • Sun Medical
    • Zeon Medical
    • その他

第8章 世界市場の特徴

  • CAD:世界市場の収益
  • 市場収益:装置の種類別

第9章 市場促進要因・機会・障壁

  • 市場促進要因
  • 市場の機会
  • 市場の障壁
  • M&A

第10章 市場分析:セグメント別

  • IABP
  • VAD
  • TAH
  • 長期の埋め込み

第11章 国別の見通しと予測

  • 米国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • 英国
  • 日本
  • 中国
  • インド
  • その他

第12章 付録

図表

目次
Product Code: GDME0175MAR

GlobalData has released its medical device report, "MediPoint: Cardiac Assist Devices - Global Analysis and Market Forecasts". The report offers a comprehensive analysis of the global Cardiac Assist Device (CAD) Market, including development and sales in the Intra-Aortic Balloon Pump (IABP), Ventricular Assist Device (VAD), and Total Artificial Heart (TAH) global markets. Included within is an examination of the drivers, opportunities and barriers impacting growth of the CAD market worldwide, with an in-depth breakdown of the CAD market seven-year forecast in the US, France, Germany, Spain, Italy, UK, Japan, China and India. The report identifies and evaluates the key trends shaping the global CAD market through 2019, highlighting testimonials from top physicians around the world utilizing the devices already. Future sales expectations are discussed through careful analysis of CAD use adoption patterns in the nine major markets. The report provides insight into the competitive CAD landscape, including new companies entering the market and pipeline products in development. It quantifies the potential of long-term cardiac assist device use in end-stage heart failure patients awaiting transplantation, and examines the impact of this disruptive technology around the world. Included in the report is investigation of the highest growth sectors for CAD, with a focus on next-generation technologies due to enter the market, including transcutaneous energy transfer and fully implantable support systems.

This report was built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of cardiovascular medical device experts.

Highlights

Key Questions Answered

  • First, second and third generation CAD are already on the market; however, unmet needs still exist in terms of efficiency, durability, and rates of infection. (Q).How will devices in development fulfill the unmet needs of the CAD market?
  • Several companies developing CAD devices have recently received approval and others are due for approval soon. (Q).How will new entrants impact a market dominated by a few, key players?
  • CAD is only recently approved for long-term use, although still only for end-stage CHF patients. (Q).How will expanded approval for use in lower-risk patients affect global revenue?
  • CAD procedure volumes have been rapidly increasing in the nine major markets. (Q).What can we expect in terms of future adoption rates leading to a mature market? (Q).How will adoption increase in developing countries?

Scope

  • Overview of congestive heart failure, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized cardiac assist device market revenue, annual cost of disease and CAD adoption pattern data from 2010-2012 and forecast for seven years to 2019.
  • Key topics covered include strategic competitor assessment, donor availability concerns, market characterization, identification of unmet needs, reimbursement considerations, and implications for cardiac assist device market growth.
  • Pipeline analysis: comprehensive data split across different stages of development, emerging trends and mechanisms of support under development, including investigation of transcutaneous energy transfer, percutaneous devices, and next-generation pumps.
  • Analysis of the current and future market competition in the global Ventricular Assist Device, Intra-Aortic Balloon Pump and Total Artificial Heart markets. Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Cardiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst

3. Disease Overview - Congestive Heart Failure

  • 3.1. Anatomy and Physiology
  • 3.2. Pathophysiology
  • 3.3. Types of Heart Failure
    • 3.3.1. Classification by Progression
    • 3.3.2. Classification by Location
    • 3.3.3. Classification by Pumping Mechanism
  • 3.4. Etiology
    • 3.4.1. Conditions That Cause Heart Failure
    • 3.4.2. Other Risk Factors
  • 3.5. Clinical Presentation
    • 3.5.1. Symptoms of Heart Failure
  • 3.6. Diagnosis of Heart Failure
    • 3.6.1. Stages of Heart Failure Based on Diagnosis
  • 3.7. Epidemiology
    • 3.7.1. Global Trends
    • 3.7.2. US
    • 3.7.3. France
    • 3.7.4. Germany
    • 3.7.5. Italy
    • 3.7.6. Spain
    • 3.7.7. UK
    • 3.7.8. Japan
    • 3.7.9. China
    • 3.7.10. India
  • 3.8. Epidemiology Forecast (2012-2019)
    • 3.8.1. Prevalent Cases of Congestive Heart Failure
  • 3.9. Clinical Outcomes
    • 3.9.1. Prognosis
    • 3.9.2. Surgical Risk Stratification
  • 3.10. Treatment Modalities
    • 3.10.1. Medication
    • 3.10.2. Surgery
    • 3.10.3. Cardiac Assistance
    • 3.10.4. Heart Transplantation
  • 3.11. Economic Impact
    • 3.11.1. Individual Costs
    • 3.11.2. Industry Costs

4. Competitive Assessment

  • 4.1. Cardiac Assist Device Market, Comparison of Key Marketed Products
  • 4.2. Ventricular Assist Devices Market, Key Company Share
  • 4.3. Ventricular Assist Devices, Comparison based on Pump Technology
  • 4.4. Ventricular Assist Devices
    • 4.4.1. Overview
    • 4.4.2. First-Generation Devices
    • 4.4.3. Second-Generation Devices
    • 4.4.4. Third-Generation Devices
    • 4.4.5. Fourth-Generation Devices
    • 4.4.6. Fifth-Generation Devices
    • 4.4.7. Sixth-Generation Devices
    • 4.4.8. Seventh-Generation Devices
    • 4.4.9. Counterpulsation Devices
    • 4.4.10. Adult Primary Implant Breakdown
    • 4.4.11. Brand-Specific Training
  • 4.5. Extracorporeal Ventricular Assist Devices
    • 4.5.1. AB5000 (Abiomed, Inc.)
    • 4.5.2. CentriMag, PediMag (Thoratec)
    • 4.5.3. Delta-Stream DP3 Pump (Medos Medizintechnik AG)
    • 4.5.4. Excor (Berlin Heart)
    • 4.5.5. PVAD (Thoratec)
    • 4.5.6. RotaFlow (Maquet Cardiovascular)
  • 4.6. Intracorporeal Ventricular Assist Devices
    • 4.6.1. DuraHeart (Terumo)
    • 4.6.2. EvaHeart (Sun Medical Technology Research Corporation)
    • 4.6.3. Heart Assist 5 (MicroMed Cardiovascular, Inc.)
    • 4.6.4. HeartMate II (Thoratec)
    • 4.6.5 HVAD (HeartWare)
    • 4.6.6. Incor (Berlin Heart)
    • 4.6.7. IVAD (Thoratec)
    • 4.6.8. Jarvik 2000 (Jarvik Heart)
  • 4.7. Percutaneous Ventricular Assist Devices
    • 4.7.1. Impella (Abiomed, Inc.)
    • 4.7.2. Synergy (CircuLite)
    • 4.7.3. TandemHeart (Cardiac Assist, Inc.)
  • 4.8. Intra-Aortic Balloon Pumps
    • 4.8.1. Overview
    • 4.8.2. AutoCAT 2 Wave (Teleflex)
    • 4.8.3. CardioSave (Maquet Cardiovascular)
    • 4.8.4. CS300 (Maquet Cardiovascular)
    • 4.8.5. iVAC (PulseCath)
    • 4.8.6. Xemex (Zeon)
  • 4.9. Extra-Aortic Balloon Pumps
    • 4.9.1. C-Pulse (Sunshine Heart)
  • 4.10. Total Artificial Heart
    • 4.10.1. Overview
    • 4.10.2. AbioCor (Abiomed)
    • 4.10.3. SynCardia (SynCardia Systems, Inc.)
  • 4.11. Extracorporeal Membrane Oxygenation

5. Unmet Needs and Opportunities

  • 5.1. Unmet Needs
    • 5.1.1. Transcutaneous Energy Transfer to Reduce Risk of Infection and Improve Lifestyle
    • 5.1.2. Anti-Coagulation to Reduce Risk of Stroke
    • 5.1.3. Thromboresistant Coatings
    • 5.1.4. Noncontact Bearing Design
  • 5.2. Opportunities
    • 5.2.1. Reduction of Rehospitalization Rates
    • 5.2.2. NYHA Class III Patients
    • 5.2.3. Destination Therapy
    • 5.2.4. Pediatrics
    • 5.2.5. Hybrid Combination Therapy
    • 5.2.6. Mitral Valve Repair

6. Pipeline Products

  • 6.1. Overview
  • 6.2. Ventricular Assist Devices
    • 6.2.1. CorAide, DexAide (Teleflex)
    • 6.2.2. DuraHeart II (Terumo)
    • 6.2.3. HeartMate III (Thoratec)
    • 6.2.4. HeartMate X (Thoratec)
    • 6.2.5. MiFlow (HeartWare)
    • 6.2.6. MiTiHeart LVAD (Mohawk Innovative Technology, Inc.)
    • 6.2.7. MVAD (HeartWare)
    • 6.2.8. PediaFlow VAD (HeartWare)
    • 6.2.9. PediPump (Cleveland Clinic)
    • 6.2.10. Revolution (Vadovations, Inc.)
    • 6.2.11. s.pump (Medos Medizintechnik AG)
  • 6.3. Percutaneous Ventricular Assist Devices
    • 6.3.1. HeartMate PHP (Thoratec)
    • 6.3.2. Reitan Catheter Pump (CardioBridge GmbH)
  • 6.4. Total Artificial Hearts
    • 6.4.1. AbioCor II (Abiomed, Inc.)
    • 6.4.2. Carmat TAH (Carmat)
    • 6.4.3. Golding TAH (Cleveland Clinic)
    • 6.4.4. Beatless Heart (Texas Heart Institute)
    • 6.4.5. MagScrew (Cleveland Clinic)
    • 6.4.6. ReinHeart (University of Aachen)
    • 6.4.7. Other

7. Current and Future Players

  • 7.1. Company Profiles
    • 7.1.1. Abiomed, Inc.
    • 7.1.2. Berlin Heart
    • 7.1.3. CardiacAssist, Inc.
    • 7.1.4. CardioBridge
    • 7.1.5. Carmat
    • 7.1.6. CircuLite
    • 7.1.7. HeartWare International, Inc.
    • 7.1.8. Jarvik Heart
    • 7.1.9. Maquet Cardiovascular
    • 7.1.10. Medos Medizintechnik AG
    • 7.1.11. MicroMed Cardiovascular, Inc.
    • 7.1.12. MiTiHeart Corporation
    • 7.1.13. PulseCath BV
    • 7.1.14. Sunshine Heart
    • 7.1.15. SynCardia Systems, Inc.
    • 7.1.16. Teleflex Medical
    • 7.1.17. Terumo
    • 7.1.18. Thoratec
    • 7.1.19. Sun Medical
    • 7.1.20. Zeon Medical
    • 7.1.21. Other

8. Global Market Characterization

  • 8.1. Cardiac Assist Device Global Revenue, 2010-2019
  • 8.2. Market Revenue by Type of Device, 2012

9. Market Drivers, Opportunities, and Barriers

  • 9.1. Market Drivers
    • 9.1.1. Increasing Heart Failure Population
    • 9.1.2. Technological Advancements, Miniaturizations, Leading to Increased Adoption by Physicians
    • 9.1.3. Extensive Clinical Studies to Improve Adoption
    • 9.1.4. Growing Patient Awareness and Increasing Numbers of Heart Centers
    • 9.1.5. Aging Population to Drive Growth in Cardiac Assist Devices Market
  • 9.2. Market Opportunities
    • 9.2.1. Highly Under-Penetrated Market to Provide Significant Opportunity
    • 9.2.2. Shortage of Donor Hearts for Transplantation Creates Opportunity
  • 9.3. Market Barriers
    • 9.3.1. Complications Associated with CAD
    • 9.3.2. High Cost Makes Treatment Unaffordable
    • 9.3.3. Alternative Therapies
    • 9.3.4. Medical Device Tax Affects Manufacturers
    • 9.3.5. Long Research and Development of Devices may Deter New Entrants into the Market
    • 9.3.6. Complications Associated with Cardiac Assist Devices might Deter Physicians from Adoption of Their Use
  • 9.4. Mergers and Acquisitions
    • 9.4.1. Potential Sunshine Acquisition

10. Market Analysis by Segment

  • 10.1. Intra-Aortic Balloon Pump: Market Characterization
    • 10.1.1. IABP Global Revenue, 2010-2019
    • 10.1.2. Global Revenue Breakdown by Type of Device, 2012
  • 10.2. Ventricular Assist Device: Market Characterization
    • 10.2.1. VAD Global Revenue, 2010-2019
    • 10.2.2. Global Revenue Breakdown by Type of Device, 2012
  • 10.3. Total Artificial Heart: Market Characterization
    • 10.3.1. TAH Global Revenue, 2010-2019
  • 10.4. Long-Term Implantation Breakdown

11. Country Outlook and Forecasts

  • 11.1. US
    • 11.1.1. Overview
    • 11.1.2. Reimbursement
    • 11.1.3. Affordable Care Act Rehospitalization Fees
    • 11.1.4. US CAD Market Revenue, 2010-2019
  • 11.2. France
    • 11.2.1. Overview
    • 11.2.2. France CAD Revenue, 2010-2019
  • 11.3. Germany
    • 11.3.1. Overview
    • 11.3.2. Germany CAD Revenue, 2010-2019
  • 11.4. Italy
    • 11.4.1. Overview
    • 11.4.2. Italy CAD Revenue, 2010-2019
  • 11.5. Spain
    • 11.5.1. Overview
    • 11.5.2. Spain CAD Revenue, 2010-2019
  • 11.6. UK
    • 11.6.1. Overview
    • 11.6.2. UK CAD Revenue, 2010-2019
  • 11.7. Japan
    • 11.7.1. Overview
    • 11.7.2. Japan Market Revenue, 2010-2019
  • 11.8. China
    • 11.8.1. Overview
    • 11.8.2. China Market Revenue, 2010-2019
  • 11.9. India
    • 11.9.1. Overview
    • 11.9.2. India Market Revenue, 2010-2019
  • 11.10. Other Countries
    • 11.10.1. Brazil
    • 11.10.2. The Netherlands

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Bibliography
  • 12.3. Methodology
    • 12.3.1. Forecasting
    • 12.3.2. Sources used
    • 12.3.3. Forecast Assumptions and Methods
  • 12.4. Coverage
  • 12.5. Secondary Research
  • 12.6. Forecasting Methodology
    • 12.6.1. Pricing Assumptions
  • 12.7. Physicians and Specialists Included in this Study
  • 12.8. Primary Research
  • 12.9. About the Authors
    • 12.9.1. Analysts
    • 12.9.2. Global Head of Healthcare
  • 12.10. Definitions
  • 12.11. About GlobalData
  • 12.12. Contact Us
  • 12.13. Disclaimer

List of Tables

  • Table 1: New York Heart Association Scale
  • Table 2: American College of Cardiology Scale
  • Table 3: Prevalent Cases of Congestive Heart Failure, All Markets, Ages ≥45 Years, Men and Women (n), 2012-2019
  • Table 4: Device Strategy at Time of Implant in US, 2011
  • Table 5: Cardiac Assist Devices by Launch
  • Table 6: Ventricular Assist Devices Market, Global, Company Share ($m), 2012
  • Table 7: Cardiac Assist Devices by Type
  • Table 8: Product Profile - AB5000
  • Table 9: AB5000 SWOT Analysis, 2012
  • Table 10: Product Profile - CentriMag, PediMag
  • Table 11: CentriMag, PediMag SWOT Analysis, 2012
  • Table 12: Product Profile - Delta-Stream DP3 Pump
  • Table 13: Delta-Stream DP3 SWOT Analysis, 2012
  • Table 14: Product Profile - Excor
  • Table 15: Excor SWOT Analysis, 2012
  • Table 16: Product Profile - PVAD
  • Table 17: PVAD SWOT Analysis, 2012
  • Table 18: Product Profile - RotaFlow
  • Table 19: RotaFlow SWOT Analysis, 2012
  • Table 20: Product Profile - DuraHeart
  • Table 21: DuraHeart SWOT Analysis, 2012
  • Table 22: Product Profile - EvaHeart
  • Table 23: EvaHeart SWOT Analysis, 2012
  • Table 24: EvaHeart US Pivotal BTT Trial
  • Table 25: Product Profile - HeartAssist 5
  • Table 26: HeartAssist 5 SWOT Analysis, 2012
  • Table 27: Product Profile - HeartMate II
  • Table 28: HeartMate II SWOT Analysis, 2012
  • Table 29: REVIVE-IT
  • Table 30: ROADMAP
  • Table 31: REMATCH
  • Table 32: Product Profile - HVAD
  • Table 33: HVAD SWOT Analysis, 2012
  • Table 34: ENDURANCE
  • Table 35: ADVANCE
  • Table 36: Product Profile - Incor
  • Table 37: Incor SWOT Analysis, 2012
  • Table 38: Product Profile - IVAD
  • Table 39: IVAD SWOT Analysis, 2012
  • Table 40: Product Profile - Jarvik 2000
  • Table 41: Jarvik 2000 SWOT Analysis, 2012
  • Table 42: Jarvik 2000 US Pivotal DT Trial
  • Table 43: Product Profile - Impella
  • Table 44: Impella SWOT Analysis, 2012
  • Table 45: Product Profile - Synergy
  • Table 46: Synergy SWOT Analysis, 2012
  • Table 47: Synergy CE Mark EU Trial
  • Table 48: Product Profile - TandemHeart
  • Table 49: TandemHeart SWOT Analysis, 2012
  • Table 50: TandemHeart to Reduce Infarct Size (TRIS)
  • Table 51: Product Profile - AutoCAT 2 Wave
  • Table 52: AutoCAT 2 SWOT Analysis, 2012
  • Table 53: Product Profile - CardioSave
  • Table 54: CardioSave SWOT Analysis, 2012
  • Table 55: Product Profile - CS300
  • Table 56: CS300 SWOT Analysis, 2012
  • Table 57: Product Profile - iVAC
  • Table 58: iVAC SWOT Analysis, 2012
  • Table 59: Product Profile - Xemex
  • Table 60: Xemex SWOT Analysis, 2012
  • Table 61: Comparing Leading CAD Products
  • Table 62: Product Profile - C-Pulse
  • Table 63: C-Pulse SWOT Analysis, 2012
  • Table 64: C-Pulse US Pivotal Trial
  • Table 65: Product Profile - AbioCor
  • Table 66: AbioCor SWOT Analysis, 2012
  • Table 67: Product Profile - SynCardia
  • Table 68: SynCardia SWOT Analysis, 2012
  • Table 69: Risk Prediction Models
  • Table 70: Cardiac Assist Devices in Pipeline
  • Table 71: Product Profile - CorAide, DexAide
  • Table 72: CorAide, DexAide SWOT Analysis, 2012
  • Table 73: Product Profile - DuraHeart II
  • Table 74: DuraHeart II SWOT Analysis, 2012
  • Table 75: Product Profile - HeartMate III
  • Table 76: HeartMate III SWOT Analysis, 2012
  • Table 77: Product Profile - HeartMate X
  • Table 78: HeartMate X SWOT Analysis, 2012
  • Table 79: Product Profile - MiFlow
  • Table 80: MiFlow SWOT Analysis, 2012
  • Table 81: Product Profile - MiTiHeart Corporation
  • Table 82: MiTiHeart SWOT Analysis, 2012
  • Table 83: Product Profile - MVAD
  • Table 84: MVAD SWOT Analysis, 2012
  • Table 85: Product Profile - PediaFlow
  • Table 86: PediaFlow SWOT Analysis, 2012
  • Table 87: Product Profile - PediPump
  • Table 88: PediPump SWOT Analysis, 2012
  • Table 89: Product Profile - Revolution
  • Table 90: Revolution SWOT Analysis, 2012
  • Table 91: Product Profile - s.pump
  • Table 92: s.pump SWOT Analysis, 2012
  • Table 93: Product Profile - HeartMate PHP
  • Table 94: HeartMate PHP SWOT Analysis, 2012
  • Table 95: Product Profile - Reitan Catheter Pump
  • Table 96: Reitan Catheter Pump SWOT Analysis, 2012
  • Table 97: Product Profile - AbioCor II
  • Table 98: AbioCor II SWOT Analysis, 2012
  • Table 99: Product Profile - Carmat
  • Table 100: Carmat SWOT Analysis, 2012
  • Table 101: Product Profile - Golding TAH
  • Table 102: Golding TAH SWOT Analysis, 2012
  • Table 103: Product Profile - Beatless Heart
  • Table 104: Beatless Heart SWOT Analysis, 2012
  • Table 105: Product Profile - MagScrew
  • Table 106: MagScrew SWOT Analysis, 2012
  • Table 107: Product Profile - ReinHeart
  • Table 108: ReinHeart SWOT Analysis, 2012
  • Table 109: Company Profile - Abiomed, Inc.
  • Table 110: Abiomed SWOT Analysis, 2012
  • Table 111: Company Profile - Berlin Heart
  • Table 112: Berlin Heart SWOT Analysis, 2012
  • Table 113: Company Profile - Cardiac Assist
  • Table 114: Cardiac Assist SWOT Analysis, 2012
  • Table 115: Company Profile - CardioBridge
  • Table 116: CardioBridge SWOT Analysis, 2012
  • Table 117: Company Profile - Carmat
  • Table 118: Carmat SWOT Analysis, 2012
  • Table 119: Company Profile - CircuLite
  • Table 120: CircuLite SWOT Analysis, 2012
  • Table 121: Company Profile - HeartWare
  • Table 122: HeartWare SWOT Analysis, 2012
  • Table 123: Company Profile - Jarvik Heart
  • Table 124: Jarvik Heart SWOT Analysis, 2012
  • Table 125: Company Profile - Maquet Cardiovascular
  • Table 126: Maquet Cardiovascular SWOT Analysis, 2012
  • Table 127: Company Profile - Medos Medizintechnik AG
  • Table 128: Medos Medizintechnik AG SWOT Analysis, 2012
  • Table 129: Company Profile - MicroMed Cardiovascular, Inc.
  • Table 130: MicroMed Cardiovascular SWOT Analysis, 2012
  • Table 131: Company Profile - MiTiHeart Corporation
  • Table 132: MiTiHeart Corporation SWOT Analysis, 2012
  • Table 133: Company Profile - PulseCath
  • Table 134: PulseCath SWOT Analysis, 2012
  • Table 135: Company Profile - Sunshine Heart
  • Table 136: Sunshine Heart SWOT Analysis, 2012
  • Table 137: Company Profile - SynCardia Systems
  • Table 138: SynCardia Systems SWOT Analysis, 2012
  • Table 139: Company Profile - Teleflex
  • Table 140: Teleflex SWOT Analysis, 2012
  • Table 141: Company Profile - Terumo Heart
  • Table 142: Terumo Heart SWOT Analysis, 2012
  • Table 143: Company Profile - Thoratec
  • Table 144: Thoratec SWOT Analysis, 2012
  • Table 145: Company Profile - Sun Medical
  • Table 146: Sun Medical SWOT Analysis, 2012
  • Table 147: Company Profile - Zeon Medical
  • Table 148: Zeon Medical SWOT Analysis, 2012
  • Table 149: CAD Global Revenue by Market Type ($m), 2010-2019
  • Table 150: Heart Failure, Prevalence (% total population, n [millions]), US, 2010-2019
  • Table 151: Population Aged 65 Years and Above as Percentage of Overall Population, Global, 1960-2050
  • Table 152: Cardiac Assist Devices, Average Selling Price ($),US, 2012
  • Table 153: IABP Forecast Global Revenue ($m), 2010-2019
  • Table 154: VAD Global Revenue ($m), 2010-2019
  • Table 155: VAD Global Revenue ($m), 2010-2019
  • Table 156: US CAD Revenue ($m), 2010-2019
  • Table 157: France CAD Revenue ($m), 2010-2019
  • Table 158: Germany CAD Revenue ($m), 2010-2019
  • Table 159: Germany CAD Revenue ($m), 2010-2019
  • Table 160: Germany CAD Revenue ($m), 2010-2019
  • Table 161: UK CAD Revenue ($m), 2010-2019
  • Table 162: Japan CAD Revenue ($m), 2010-2019
  • Table 163: China CAD Revenue ($m), 2010-2019
  • Table 164: India CAD Revenue ($m), 2010-2019
  • Table 165: Sources of Epidemiological Data Used for the Forecast
  • Table 166: New York Heart Association (NYHA) Class Distributions Description

List of Figures

  • Figure 1: Classifications of Heart Failure
  • Figure 2: Stages of Heart Failure Based on Diagnosis
  • Figure 3: Treatment Modalities for Heart Failure
  • Figure 4: Ventricular Assist Devices Market, Global, Company Share (%), 2012
  • Figure 5: CAD Global Revenue by Market Type ($m), 2009-2012
  • Figure 6: Cardiac Assist Devices Market Revenue by Type of Device (%), 2012
  • Figure 7: Cardiac Assist Devices, Market Dynamics
  • Figure 8: Heart Failure, Prevalence (million), US, 2010-2019
  • Figure 9: Population Aged 65 Years and Above as Percentage of Overall Population, Global, 1960-2050
  • Figure 10: IABP Global Revenue ($m), 2010-2019
  • Figure 11: Global Market Revenue by Type of Device, 2012
  • Figure 12: VAD Global Revenue, 2010-2019 ($m)
  • Figure 13: Global Market Revenue by Type of Device, 2012
  • Figure 14: TAH Global Revenue ($m), 2010-2019
  • Figure 15: Breakdown of Long-Term Interventions by Type, 2011
  • Figure 16: US CAD Revenue ($m), 2010-2019
  • Figure 17: CAD Purchases vs. Heart Transplants, US (N), 2010-2019
  • Figure 18: France CAD Revenue ($m), 2010-2019
  • Figure 19: Germany CAD Revenue ($m), 2010-2019
  • Figure 20: Italy CAD Revenue ($m), 2010-2019
  • Figure 21: Spain CAD Revenue ($m), 2010-2019
  • Figure 22: UK CAD Revenue ($m), 2010-2019
  • Figure 23: Japan CAD Revenue ($m), 2010-2019
  • Figure 24: China CAD Revenue ($m), 2010-2019
  • Figure 25: India CAD Revenue ($m), 2010-2019
Back to Top